The Current Ratio as of September 2024 (TTM) for Stevanato Group S.p.A. (STVN) is 1.74

According to Stevanato Group S.p.A.’s latest financial reports and current stock price. The company's current Current Ratio is 1.74. This represents a change of 14.54% compared to the average of 1.52 of the last 4 quarters.

Stevanato Group S.p.A. (STVN) Historical Current Ratio (quarterly & annually)

How has STVN Current Ratio performed in the past?

The mean historical Current Ratio of Stevanato Group S.p.A. over the last ten years is 1.80. The current 1.74 Current Ratio has changed 9.60% with respect to the historical average. Over the past ten years (40 quarters), STVN's Current Ratio was at its highest in in the September 2021 quarter at 2.66. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Stevanato Group S.p.A. (STVN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Stevanato Group S.p.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Stevanato Group S.p.A. (STVN) Average Current Ratio

How has STVN Current Ratio performed in the past?

The current Current Ratio of Stevanato Group S.p.A. (STVN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Stevanato Group S.p.A. (STVN) Current Ratio vs. Peers

How is STVN’s Current Ratio compared to its peers?

Stevanato Group S.p.A.’s Current Ratio is less than Haemonetics Corporation (3.76), less than Merit Medical Systems, Inc. (6.24), less than AngioDynamics, Inc. (2.12), greater than AptarGroup, Inc. (1.36), less than Envista Holdings Corporation (2.22), less than ICU Medical, Inc. (2.40), less than The Cooper Companies, Inc. (1.99), less than Teleflex Incorporated (2.58), less than West Pharmaceutical Services, Inc. (2.34), less than Alcon Inc. (2.56), less than ResMed Inc. (2.59), greater than DENTSPLY SIRONA Inc. (1.33), less than AtriCure, Inc. (4.13), less than Akoya Biosciences, Inc. (2.73),

Build a custom stock screener for Stevanato Group S.p.A. (STVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Stevanato Group S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Stevanato Group S.p.A. (STVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Stevanato Group S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.